JUBLPHARMA — Jubilant Pharmova Balance Sheet
0.000.00%
- IN₹152.72bn
- IN₹174.03bn
- IN₹82.80bn
Annual balance sheet for Jubilant Pharmova, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9,803 | 10,108 | 9,539 | 10,862 | 12,652 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11,469 | 12,125 | 12,709 | 11,537 | 14,649 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 35,092 | 37,624 | 38,761 | 35,772 | 41,093 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 27,911 | 33,651 | 36,871 | 51,682 | 69,033 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 99,909 | 111,566 | 115,485 | 127,564 | 155,227 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15,916 | 17,724 | 18,890 | 21,646 | 25,389 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 46,723 | 57,574 | 61,146 | 65,015 | 84,299 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 53,186 | 53,993 | 54,339 | 62,549 | 70,928 |
| Total Liabilities & Shareholders' Equity | 99,909 | 111,566 | 115,485 | 127,564 | 155,227 |
| Total Common Shares Outstanding |